Bio Marketing
Eisai Expands Direct Presence in Saudi Arabia with New Pharmaceutical Sales Subsidiary
Eisai announced the commencement of full-scale operations at Eisai Pharmaceuticals Single Person Limited Liability Company (Eisai Saudi Arabia), a wholly-o...
October 02, 2024 | News
Zuellig Pharma Secures Exclusive Distribution Agreement with Regeneron to Launch Libtayo® in South Korea and Taiwan
Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owne...
August 28, 2024 | News
CBC Group and Hasten Biopharmaceutical Acquire Asset Rights of 14 Branded Products from Celltrion in Major Pan-Asia Expansion
CBC Group (“CBC”), Asia’s largest healthcare-dedicated asset management firm headquartered in Singapore, announced that its control...
July 01, 2024 | News
Juniper Biologics Expands Distribution Rights for Caris Life Sciences' Advanced Cancer Profiling Services to Middle East and Africa
Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, h...
June 24, 2024 | News
Luye Pharma Licenses Rivastigmine Patch to Myung In Pharm for South Korea Commercialization
The agreement for the collaboration was signed at a ceremony attended by executives from both sides. Dianbo Liu, Chairman of the Board of Directors of Luye...
February 06, 2024 | News
CanariaBio and Hikma Sign Oregovomab Distribution and License Deal for MENA Region
"We are thrilled to partner with Hikma, a company with a strong presence in the MENA region and a proven track record of successful collaborations," said&n...
October 11, 2023 | News
Vela Diagnostics Collaborates with SRL Inc. for Product Distribution in Japan
Established in 1970, SRL Inc (a subsidiary of H.U Group Holdings Inc.), is a renowned clinical laboratory testing company in Japan with over 80 n...
October 03, 2023 | News
BioRay's Zuberitamab (Anruixi®) First Domestic Anti-CD20 Antibody Approved in China
In preclinical studies, Anruixi® showed stronger antibody-dependent cell-mediated cytotoxicity (ADCC), a larger volume of distribution at steady state,...
September 14, 2023 | News
Companies Embracing Rebranding in Biotech, Life Sciences, and Biopharma
Companies in these sectors often find it essential to adapt to changing market dynamics, emerging technologies, and shifting consumer expectations. One eff...
September 07, 2023 | Analysis
iotaSciences and Quantum Design China Enter into Distribution Agreement
iotaSciences, the Oxford-based leader in the rapidly growing field of single-cell handling solutions, and Quantum Design China, a subsidiary of Quantum Des...
September 07, 2023 | News
Daewoong Pharmaceutical Introduces 'Fexuprazan' with Global Export to the Philippines
Daewoong Pharmaceutical (CEO Jeon Seng-ho, Lee Chang-jae) announced that 'Fuxuprazan' is officially launched in the Philippines o...
August 17, 2023 | News
OmiGroup Unveils New Brand Identity and The Pioneer Mission for Japan Digital Healthcare
OmiGroup, a prominent brand, has recently undergone a significant transformation, introducing a refreshed logo and redefined core values. Howeve...
June 22, 2023 | News
Viseven and SpotMe Join Forces for Digital Transformation
Driving Success in Pharma Communication The partnership between Viseven and SpotMe creates a unique point of view on the HCP engagement and B2B event orga...
June 21, 2023 | News
Sun Pharma and Philogen Sign Exclusive Agreement for NIDLEGY™ Commercialization in Europe, Australia, and New Zealand
Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy™ for indications of skin cancers in the territories ...
May 31, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
